Aripiprazole as an adjuvant treatment for obsessive and compulsive symptoms in manic phase of bipolar disorder: A randomized, double-blind, placebo-controlled clinical trial
Author:
Funder
Shiraz University of Medical Sciences
Publisher
Elsevier BV
Subject
Biological Psychiatry,Pharmacology
Reference41 articles.
1. Successful treatment response with aripiprazole augmentation of SSRIs in refractory obsessive-compulsive disorder in childhood;Akyol Ardic;Child Psychiatry Hum. Dev.,2017
2. Clinical, psychological and environmental predictors of prospective suicide events in patients with bipolar disorder;Antypa;J. Psychiatr. Res.,2013
3. Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials;Barth;Br. J. Psychiatry,2016
4. A systematic review: antipsychotic augmentation with treatment refractory obsessive-compulsive disorder;Bloch;Mol. Psychiatry,2016
5. Obsessive-compulsive disorder, which genes? Which functions? Which pathways? An integrated holistic view regarding OCD and its complex genetic etiology;Bozorgmehr;J. Neurogenet.,2017
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparison of Aripiprazole and Risperidone effectiveness in treating obsessive‐compulsive disorder in patients with bipolar disorder: Double‐blind, randomized clinical trial;Health Science Reports;2023-08
2. Enhanced Solubility and Stability of Aripiprazole in Binary and Ternary Inclusion Complexes Using Hydroxy Propyl Beta Cyclodextrin (HPβCD) and L-Arginine;Molecules;2023-05-03
3. Comorbidities in Youth with Bipolar Disorder: Clinical Features and Pharmacological Management;Current Neuropharmacology;2023-04
4. Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects;International Journal of Neuropsychopharmacology;2022-08-06
5. Is mirtazapine augmentation effective for patients with obsessive-compulsive disorder who failed to respond to sertraline monotherapy? A placebo-controlled, double-blind, clinical trial;International Clinical Psychopharmacology;2022-06-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3